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The  safety  and  protective  efﬁcacy  of a  new  octavalent  combination  vaccine  containing  inactivated
Erysipelothrix  rhusiopathiae,  Parvovirus,  and  Leptospira  interrogans  (sensu  lato)  serogroups  Cani-
cola,  Icterohaemorrhagiae,  Australis  (Bratislava),  Grippotyphosa,  Pomona  and  Tarassovi  – Porcilis®
Ery  + Parvo  +  Lepto  – was evaluated  in  laboratory  studies  and  under  ﬁeld  conditions.
The  safety  (2× overdose  and  repeated  dose)  was tested  in 26  gilts.  In this  study,  neither  vaccine  related
temperature  increase  nor  other  systemic  reactions  were  observed  after intramuscular  vaccination.  No
local  reactions  were  observed  except  for  one  animal  that  had  a small  local  reaction  (2 cm  diameter)  that
lasted  for  5 days  after  the  third  vaccination.
Efﬁcacy  was  tested  in  40 gilts.  A group  of 20 gilts  was  vaccinated  at 20 and  24  weeks of  age  with
Porcilis® Ery  +  Parvo  + Lepto  and  a group of 20 age-  and  source-matched  animals  served  as  the  control
group.  The gilts  were  inseminated  at 41  weeks  or 66  weeks  of  age  and  were  challenged  with serovar
Pomona  10  weeks  after insemination,  corresponding  to 6 months  (n  =  2 ×  10)  and  12  months  (n =  2  ×  10)
after  the  last  vaccination.  After both  the 6-  and  12-month  challenges  the  control  animals  developed  clin-
ical signs  (fever,  lethargy  and  anorexia)  and  leptospiraemia  as  determined  by  positive  blood  culture.  In
addition,  both  the 6- and  12-month  challenges  resulted  in  death  of 21% and  27% of  the  total  number  of
foetuses  in the control  groups,  respectively.  Clinical  signs  and  leptospiraemia  were  statistically  signiﬁ-
cantly lower  in  vaccinated  gilts  after  both  the  6- and  12-month  challenges.  In  addition,  foetal  death  was
statistically  signiﬁcantly  lower  (3%  and  2%,  respectively)  in  vaccinated  gilts  after  both  the  6- and  12 month
challenges.
The vaccine  was  tested  further  under  ﬁeld  conditions  on  a  Portuguese  farm  with  a history  of an  increas-
ing  abortion  rate  associated  with  a Leptospira  serovar  Pomona  infection  (conﬁrmed  by  PCR  and  serology).
This  study  was  designed  as an  observational-longitudinal  ﬁeld  study.  At  the  start  of the  study,  all  breed-
ing  sows  and  replacement  gilts  on the  farm  were  vaccinated  twice  with  Porcilis® Ery  +  Parvo  + Lepto  at
an  interval  of 4 weeks.  Starting  six  months  after  the primary  vaccination  schedule,  the  animals  were
re-vaccinated  during  the  second  week  of every  subsequent  lactation.  New  replacement  gilts  were  vacci-
nated  using  the same  schedule.  After vaccination,  the  abortion  rate  reduced  rapidly  from  12.6% in  winter
months  of  2012  (December  2011  to March  2012)  to  0.5% in  winter  months  of  2013,  a statistical  signiﬁ-
cant  decrease  of  96%.  The  total  number  of  abortions  on  the  farm  decreased  from  55  in 2012  to 6 in 2013.
Thereafter,  the  abortion  rate remained  stable  and in  the  period  December  2013  to  April  2014  was still
low  (0.6%).In conclusion,  the  present  studies  demonstrate  that  the  octavalent  Porcilis® Ery  +  Parvo  +  Lepto  vac-
cine  can  be  safely  used  in  gilts  and  sows  and  induces  signiﬁcant  protection,  for the  duration  of  at  least
one  year,  against  serovar  Pomona  induced  clinical  signs,  leptospiraemia  and foetal  death.  Protection
against  Pomona  associated  reproductive  failure  was  conﬁrmed  under  ﬁeld  conditions  where  a  signiﬁcant
 was erved.reduction  in  abortion  rate
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. Introduction
Swine erysipelas is an economically important disease world-
ide. It is caused by the bacterium Erysipelothrix rhusiopathiae and
s manifested as acute or subacute septicaemia and chronic prolifer-
tive lesions. The acute form is characterized by typical rhomboid
diamond-shaped), urticarial skin lesions and fever, whereas the
hronic form is characterized by arthritis [1].
Porcine parvovirus is a common and important cause of infec-
ious infertility and has been found to be present in the majority of
ig herds. Parvovirus infection in adult pigs rarely, if ever, causes
linical signs. However, the virus readily crosses the placental bar-
ier with lethal effects on the embryos and foetuses in susceptible
regnant animals. Depending on the stage of pregnancy, this will
esult in resorption and return to heat or mummiﬁcation of the
mbryos, which will be delivered at term together with a variable
umber of weak or healthy piglets [2].
Leptospirosis, caused by Leptospira interrogans sensu lato, is also
 cause of reproductive failure in pigs worldwide, which manifests
tself as abortions or the birth at term of a variable number of mum-
iﬁed, autolysed, stillborn and/or weak piglets [3–5]. Leptospirosis
n pigs, as in other animals and humans, is difﬁcult to diagnose and
ts incidence is most probably underestimated. Culture, serology
nd PCR often are negative even when active infection is present.
n addition, in sows, the clinical signs of Leptospira infection are
ew, vague and non-speciﬁc or absent [3–5].
Vaccines against Erysipelas and Parvovirus are routinely used
n the pig industry whereas leptospirosis vaccines are used less
ommonly. For convenience of the user and to reduce the number
f injections given to gilts and sows, a ready-to-use combination
roduct including Leptospira would be highly desirable. Therefore,
e developed a new, ready-to-use combination product by adding
ix relevant swine Leptospira antigens (serogroups Canicola, Ictero-
aemorrhagiae, Australis (Bratislava), Grippotyphosa, Pomona and
arassovi) to an existing vaccine, Porcilis® Ery + Parvo. This new
ombination vaccine was subsequently tested for safety and efﬁ-
acy against each of the infectious agents. The present study focuses
n the demonstration of vaccine efﬁcacy against Pomona, the most
otorious Leptospira serovar associated with foetal death [6], under
ontrolled laboratory and ﬁeld conditions.
. Materials and methods
.1. Vaccines
A vaccine containing inactivated E. rhusiopathiae,  Parvovirus, L.
nterrogans (sensu lato) serogroups Canicola, Icterohaemorrhagiae,
ustralis (Bratislava), Grippotyphosa, Pomona and Tarassovi and
he Diluvac Forte® adjuvant (Porcilis® Ery + Parvo + Lepto, MSD  Ani-
al  Health). For vaccine preparation a mixture of the eight antigens
t proper concentration was 1:1 mixed with double concentrated
iluvac Forte® adjuvant. The Diluvac Forte Adjuvant is a Vitamin E
ased oil (non-mineral oil) in water emulsion.
A vaccine containing inactivated E. rhusiopathiae and parvovirus
nd Diluvac Forte® adjuvant (Porcilis® Ery + Parvo, MSD  Animal
ealth) that was  administered to the control animals in the efﬁcacy
tudies.
A vaccine containing live attenuated PRRS virus (Porcilis® PRRS,
SD  Animal Health) that was administered concurrently to the pigs
n the safety study.
.2. Leptospira strainsThe Leptospira strains used for the vaccine preparation were
. interrogans, serogroup Canicola, serovar Portland-vere, strain
a-12-000; L. interrogans, serogroup Icterohaemorrhagiae, serovar33 (2015) 3963–3969
Copenhageni, strain Ic-02-001; Leptospira kirschneri,  serogroup
Grippotyphosa, serovar Dadas, strain Gr-01-005; L. interrogans,
serogroup Australis, serovar Bratislava, strain As-05-073; L. inter-
rogans, serogroup Pomona, serovar Pomona, strain Po-01-000,
Leptospira santarosai,  serogroup Tarassovi, serovar Gatuni, strain
S-1148/02.
The Leptospira challenge strain used was  L. interrogans,
serogroup Pomona, serovar Pomona, strain 02-0162. All strains
were obtained at an unknown passage level and all except for strain
S-1148/02 were obtained from Dr. C. Bolin, USD, NADC, USA. The
Tarassovi strain S-1148/02 was  obtained from Queensland Health
Science Services, Australia.
After arrival the strains had 2–3 EMJH medium passages after
which they were stored in liquid nitrogen. The vaccine strains had
5–7 further medium passages before they were used in the vac-
cine. After arrival, the Pomona challenge strain was  passed through
hamsters and after re-isolation and two  medium passages stored in
liquid nitrogen. Before challenge this strain had two further EMJH
medium passages.
2.3. Laboratory safety study
Twenty-six gilts, 16 weeks of age, with undetectable levels of
antibodies to E. rhusiopathiae,  Parvovirus, PRRS virus and Leptospira
serogroups Canicola, Icterohaemorrhagiae, Australis (Bratislava),
Grippotyphosa, Pomona and Tarassovi, were used. A group of 12
gilts was  vaccinated with a single dose of 2 ml intramuscularly in
the neck with Porcilis® Ery + Parvo + Lepto and was necropsied two
weeks later. The vaccine injection site of these pigs was  investigated
post-mortem for any local tissue reactions or vaccine remnants.
A second group of 14 gilts was vaccinated with a standard dose
of Porcilis PRRS (left side) and a double dose (4 ml, right side) of
Porcilis® Ery + Parvo + Lepto, followed by two single doses of both
vaccines with two week intervals between the vaccinations. All pigs
were observed daily for local and systemic reactions during 14 days
after each vaccination. Rectal temperature was determined on day
1, 2 and 3 before each vaccination, just before vaccination, 4 h after
vaccination and then once daily for four days after each vaccination.
2.4. Laboratory efﬁcacy study
2.4.1. Study design
Forty gilts, 20 weeks of age, with undetectable levels of
serum antibodies against Leptospira serogroups Canicola, Ictero-
haemorrhagiae, Australis (Bratislava), Grippotyphosa, Pomona and
Tarassovi, were used. Twenty gilts were vaccinated twice with
Porcilis® Ery + Parvo + Lepto (vaccinates) with a 4-week interval
between vaccinations. The other 20 were vaccinated with a com-
mercial batch of Porcilis® Ery + Parvo (controls) using the same
vaccination schedule. Twenty gilts (10 vaccinates and 10 controls)
were inseminated, after oestrus synchronization, at 41 weeks of
age. The other 20 gilts were inseminated, after oestrus synchroniza-
tion, at 66 weeks of age. The pigs were challenged intravenously
(10 ml) and conjunctivally (0.25 ml  per eye) with a culture of a
virulent strain of Leptospira serovar Pomona, strain 02-0162 (109
bacteria/ml) 10 weeks after insemination (i.e. 6 or 12 months after
the last vaccination). Before challenge one animal was lost due
to recurrent locomotory problems, leaving 9 animals for the 12
months challenge control group.
Blood samples were taken for serology, using the microscopic
agglutination test (MAT), after vaccination and challenge. Blood and
urine samples were taken before and after challenge to isolate the
challenge strain.
The pigs were observed regularly for clinical signs, including
lethargy, anorexia and abortion, for up to 4 weeks after challenge.
Rectal temperature was measured the day before challenge, the
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ay of challenge (just before) and on days 1, 2, 3, 4, 7 and 10 after
hallenge.
The pigs were euthanized 4 weeks after challenge. Necropsy was
erformed and the state of the pregnancy and condition of the foe-
uses were evaluated. Kidney samples were taken from all pigs and
 representative foetus, along with peritoneal ﬂuid, for re-isolation
f challenge organisms.
.4.2. Serology
Blood samples were collected from each pig on the day of vac-
ination and 4, 6, 12, 31 and 56 weeks after vaccination into Serum
ep. Clot Activator tubes (without anticoagulant, for preparation
f serum). Additional blood samples were collected 4 weeks after
hallenge. The serum samples were stored frozen until analysis.
erogroup speciﬁc agglutination titres were determined using the
icroscopic agglutination (MAT) test as described previously [7].
.4.3. Isolation of challenge organisms from blood, urine, kidney
r peritoneal ﬂuid
To isolate the challenge strain, blood samples were taken, into
eparinized tubes, just before challenge, 5 hours after challenge and
n days 1, 2, 3, 4, 7 and 10 post-challenge. Urine was  sampled just
efore challenge and on days 14, 17, 21, 24 and 28 post-challenge
or re-isolation of challenge strain. At necropsy, a 1–2 g sample was
aken from the renal cortex of one kidney of each sow. At necropsy,
 kidney sample and peritoneal ﬂuid (0.5 ml)  was collected from
he smallest viable foetus from each pig.
Blood (heparinized) or urine samples (0.5 ml)  were added to
0 ml  of liquid EMJH medium containing 200 g/ml 5-ﬂuorouracil
nd 1% (v/v) rabbit serum negative for agglutinating antibodies
gainst the 6 different serovars included in the vaccine. Each kid-
ey sample was put into liquid EMJH medium (as described above)
nd homogenized using an Ultraturrax. A 100-fold dilution of the
idney homogenate was cultured in liquid EMJH medium. Peri-
oneal ﬂuid (0.5 ml)  was inoculated directly into 4.5 ml  liquid EMJH
edium.
The samples were then incubated at 28–30 ◦C, and observed
ortnightly using dark-ﬁeld microscopy for at least 8 weeks before
egative cultures were discarded. The identity of the isolates was
onﬁrmed using the MAT  test with speciﬁc anti-sera.
.4.4. Evaluation of pregnancy
Ultrasonography was  performed 4 weeks after insemination and
ust before challenge to conﬁrm pregnancy. After challenge the pigs
ere observed for abortions by visual inspection and the uterine
ontents were examined post mortem.
.4.5. Necropsy
At the end of the study (28 days after challenge) the sows were
uthanized humanely using electric stunning followed by exsan-
uination, and immediately thereafter necropsy. Macroscopic post
ortem examination focussed particularly on the lungs, liver,
idneys and spleen. Where macroscopic tissue changes or abnor-
alities were observed, samples were collected for histological
xamination. In addition the uterine contents were evaluated for
oetal viability, recent foetal death, foetal maceration and mummi-
cation. Kidney samples were taken from all gilts and from selected
oetuses along with peritoneal ﬂuid for isolation of the challenge
rganism.
.5. Field studyAn observational-longitudinal ﬁeld study was conducted on a
arm in Portugal with a history of increasing abortion rates associ-
ted with Leptospira infection.33 (2015) 3963–3969 3965
At the start of the study, all breeding sows and replace-
ment gilts on the farm were vaccinated twice with Porcilis®
Ery + Parvo + Lepto with an interval of 4 weeks. Starting six months
after the primary vaccination schedule, the animals were re-
vaccinated in the second week of every subsequent lactation. New
replacement gilts were vaccinated according to the same schedule.
The reproductive performance was monitored and farrowing
results and relevant breeding data were collected to determine if
vaccination had any effect on the incidence of abortion. The results
from the study period were compared to the historical data.
2.6. Statistical analysis
The level of signiﬁcance  ˛ was  set at 0.05 and all tests were
two sided. Statistical analyses were carried out using the statistical
programme SAS V9.1 or higher (SAS Institute Inc. Cary NC, USA).
2.6.1. Rectal temperature
In the laboratory efﬁcacy study, the rectal temperature data over
time were statistically evaluated by a linear mixed model ANOVA,
using the pre-challenge values as baseline and taking into account
the repeated measurement structure of the data [8]. In addition,
the effect of vaccination on rectal temperature was evaluated on
the peak increase and the Area under the Curve (AUC) of the rectal
temperature over time, using for both the pre-challenge data as
baseline. AUC was calculated by the linear trapezoidal rule. AUC
and the Peak response were statistically evaluated by ANOVA.
2.6.2. Clinical signs: lethargy/anorexia
The duration of clinical signs of lethargy and/or anorexia
observed for each animal was analyzed by ANOVA and in addition
the number of pigs showing these signs was analyzed using Fisher’s
exact test.
2.6.3. Bacterial isolation from blood
Bacterial re-isolation data over time in blood, categorized as
positive or negative were statistically evaluated by Generalized
Estimating Equations (GEE, with binary distribution and the logit
as link function), taking into account the repeated measurement
structure of the data [9]. In addition the duration of days positive
was evaluated by ANOVA.
2.6.4. Foetal death after challenge
At necropsy, foetuses were scored as viable or dead. Dead foe-
tuses were subdivided into recent death, macerated or mummiﬁed.
The length (cm) of mummiﬁed foetuses was  measured in order
to be able to estimate the age at death using the formula: length
(in mm)  = 3.25x − 70.59, where x = days of gestation [10]. Since
challenge took place on day 70 of gestation, mummies ≤15.7 cm
were regarded as having died before challenge (aspeciﬁc cause)
whereas mummies >15.7 cm were regarded as having died after
challenge. The total number of foetuses that died after challenge
was calculated by the addition of mummies >15.7 cm + macerated
foetuses + recent foetal death. The number of dead foetuses that
died after challenge as fraction of the total number of foetuses from
that litter was  analyzed by Poisson regression, with the effect of
litter taken into account (GEE) [9].
2.6.5. Evaluation of ﬁeld study
Abortion rate per year was  analyzed by logistic regression usinga log linear model to estimate the relative risk on an abortion [9,11].
A year was deﬁned as the period of 1 December in any calendar year
to 30 November in the subsequent calendar year e.g. 2012 was from
1 December 2011 to 30 November 2012.
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Table 1
Reproductive performance of pregnant gilts challenged with serovar Pomona at 10 weeks of gestation and 6 or 12 months after vaccination.
Group Time after vaccination n Number of foetuses Logistic regression GEE
Total Total alive Total dead Dead beforea Dead afterb % Dead after challenge
vac 6 (months) 10 128 121 7 4 3 3 p = 0.0003
con  6 (months) 10 150 104 46 15 31 21
vac  12 (months) 10 145 138 7 4 3 2 p = 0.0076
con  12 (months) 9 128 83 45 11 34 27
3
3
t
F
(
E
o
d
(a Mummies <15.7 cm length.
b Mummies/foetuses >15.7 cm length.
. Results.1. Laboratory safety study
No vaccine-related rectal temperature increase or other sys-
emic reactions were observed after vaccination (data not shown).
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gilt, which had a small local reaction (2 cm diameter) for 5 days after
the third vaccination. At necropsy injection site reactions, charac-
terized by pale tissue discoloration, were observed macroscopically
in two animals. Histologically, these reactions appeared to consist
of limited granulomatous inﬂammatory tissue.
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Table 2
Serological results of Portuguese farm (36 sera tested).
MAT  titre Frequency of MAT  titre
log2 Canicola Ictero Bratislava Grippo Pomona Tarassovi
≤2 34 36 36 35 31 36
3  2 0 0 0 1 0
4  0 0 0 1 0 0
5  0 0 0 0 0 0
6  0 0 0 0 0 0
7  0 0 0 0 2 0
8  0 0 0 0 0 0
were signiﬁcantly lower than in 2011 and 2012.
Table 3
Reproduction data Portuguese ﬁeld trial.
Period 01.12.09 01.12.10 01.12.11 01.12.12 01.12.13
30.11.10 30.11.11 30.11.12 30.11.13 30.04.14
Farrows (N) 1244 1275 1253 1206 489
Abortions (N) 11 29 55 6 3
%  Abortions 0.9 2.3 4.4 0.5 0.6
Total born (avg) 13.3 14.1 14.0 15.3 15.0
Born alive (avg) 12.3 12.9 13.0 14.4 14.0
Wean (avg) 10.9 11.5 11.7 12.8 12.5
%  Stilbirths 7.5 8.5 7.1 5.5 6.7A.A.C. Jacobs et al. / Va
.2. Laboratory efﬁcacy study
.2.1. Serology
After vaccination, approximately half of the vaccinated gilts
eveloped detectable MAT  titres against serovar Pomona. The aver-
ge titres peaked 2 weeks after second vaccination (range 0–8 log2)
fter which they declined and many vaccinates were seronega-
ive by the day of challenge (Fig. 1A and B). The control animals
emained seronegative until challenge. All pigs showed a strong
ncrease in serum antibody titre after challenge, at 6 or 12 months.
here was a more marked increase in serum antibody titres in the
ontrols than in the vaccinates.
.2.2. Rectal temperature
An increase in average rectal temperature was seen in the con-
rols at day 2 after challenge, at 6 or 12 months (Fig. 1C and D). There
as a statistically signiﬁcant difference in the peak rectal tempera-
ure after challenge between the vaccinates and controls; p = 0.0002
t 6 months and p < 0.0001 at 12 months. The area under the rectal
emperature curve (AUC) was signiﬁcantly lower in the vaccinates
ompared to the controls; p = 0.0020 and p = 0.0075, respectively.
.2.3. Clinical signs
Lethargy and/or anorexia was observed in all of the controls
rom day 2 after challenge, whereas most of the vaccinates did
ot show clinical signs (data not shown). The duration of clinical
igns was signiﬁcantly shorter in the vaccinates than in the controls
fter both the 6 and 12 months challenge; p = 0.0002 and p = 0.0110,
espectively. The incidence of lethargy was signiﬁcantly lower in
he vaccinates than in the controls after the 6 months challenge
p < 0.0001) but not after the 12 months challenge (p = 0.1789).
.2.4. Re-isolation of challenge organisms from blood and urine
After challenge all of the controls became infected and were
eptospiraemic for 3–4 days (Fig. 1E and F). After the 6-month
hallenge, both the number of pigs infected (p = 0.0031) as well as
he number of days positive (p < 0.0001) were signiﬁcantly differ-
nt between the vaccinates and the controls. After the 12-month
hallenge, the number of pigs infected did not differ signiﬁcantly
etween groups (p = 0.4370) but the vaccinates were culture posi-
ive for signiﬁcantly fewer days than the controls (p = 0.0048).
There were no positive urine cultures following challenge in
ither group.
.2.5. Reproductive performance
No macroscopic tissue changes were found outside the uterus at
ecropsy. There was more foetal death, autolysis and/or mummiﬁ-
ation in the controls than in the vaccinates (Table 1). The number
f dead foetuses after challenge as a fraction of litter size was sig-
iﬁcantly lower in the vaccinates than in the controls following
hallenge at 6 (p = 0.0003) or 12 months p = 0.0076.
All kidney cultures (sow and foetus) were Leptospira negative
xcept for one control sow from the 12-month challenge group.
ne foetal peritoneal ﬂuid sample from the controls at the 6-month
hallenge and two samples from the controls at the 12-month chal-
enge were Pomona culture positive.
.3. Field study results
.3.1. Field study results pre-vaccination
Abortions had a seasonal pattern peaking in the four winter
onths. They ﬁrst appeared in 2011 when the abortion rate rose to
% in the four winter months (and 2.3% over the whole year period).
o action was taken at this time because the abortion rate was
ot alarming. The situation deteriorated in 2012 when the abor-
ion rate reached 12.6% in the winter months (and 4.4% over the9  0 0 0 0 2 0
whole year period). Abortions were late in gestation and no other
clinical signs were observed at that time on the farm. Leptospira
was diagnosed from aborted foetal material sent to a regional vet-
erinary diagnostic laboratory. In December 2011, aborted foetuses
were PCR positive for Leptospira and negative on PCR for PRRSV and
in January 2012 aborted foetal material was again PCR positive for
Leptospira and negative on PCR for Toxoplasma. The former results
were conﬁrmed by another diagnostic laboratory using PCR for Lep-
tospira and serology for PRRSV. In March 2012, blood samples were
taken at random from 36 pigs and sera tested in the MAT  test. High
MAT  titres (up to 9 log2) against serogroup Pomona were found
in four animals whereas titres against other serogroups (includ-
ing Canicola, Icterohaemorrhagiae, Grippotyphosa, Australis and
Tarassovi) were virtually absent, indicating a recent Leptospira
serovar Pomona infection (Table 2).
Because of the abortion storm and the Pomona positive and
PRRSV negative diagnosis; this farm was  selected for a ﬁeld study
using Porcilis® Ery + Parvo + Lepto. At the start of the study (Oct-
Nov 2012), all breeding sows and replacement gilts on the farm
were vaccinated with Porcilis® Ery + Parvo + Lepto.
3.3.2. Field study results post-vaccination
After vaccination, the abortion rate reduced rapidly from 12.6%
in winter months of 2012 (December 2011 to March 2012) to 0.5% in
winter months of 2013, a statistically signiﬁcant decrease of 96%.
The total number of abortions on the farm decreased from 55 in
2012 to 6 in 2013 (Table 3 and Fig. 2). The number of abortions
on the farm remained stable after the vaccination programme was
started and was 0.6% in the period December 2013 to April 2014.
The results of logistic regression are summarized in Table 4. There
was no statistically signiﬁcant difference in the abortion rate in the
years 2010, 2013 and 2014 but the abortion rates in these years%  Wean mortality 11.4 10.9 10.0 11.1 10.7
Sows total 1338 1381 1398 1336 476
Pregnant (N) 1267 1305 1259 1247 441
%  Pregnant 94.7 94.5 90.1 93.3 92.6
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Table 4
Summary statistical results abortion rate.
Comparison periods Relative risk on abortion Lower limit 95%CI Upper limit 95%CI p-Value (Type 3)
2014b vs 2010a 0.70 0.19 2.48 0.5632
2013  vs 2010 0.56 0.21 1.52 0.2484
2014  vs 2013 1.23 0.31 4.91 0.7703
2010  vs 2011 0.39 0.20 0.79 0.0051
2013  vs 2011 0.22 0.09 0.53 0.0001
2014  vs 2011 0.27 0.08 0.90 0.0107
2010  vs 2012 0.21 0.11 0.40 <0.0001
2013  vs 2012 0.12 0.05 0.27 <0.0001
2014 vs 2012 0.15 0.05 0.46 <0.0001
2011  vs 2012 0.53 0.34 0.82 0.0038
a Period 2010, 2011, 2012 and 2013 is from 1st Dec.–30 Nov. of the subsequent year.
b Period 2014 is from 1st Dec. 2013–30 Apr. 2014.
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Fig. 2. Time-course of per cent abortions on a Portuguese farm before and after
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iaccination with Porcilis® Ery + Parvo + Lepto; vaccination was  started in October
012. There was  a statistically signiﬁcant reduction in abortion rate after vaccination
p  < 0.05, logistic regression analysis) compared to previous years.
. Discussion
The present study supports the safety of the new Porcilis®
ry + Parvo + Lepto vaccine in gilts. An increase in rectal tempera-
ure, commonly observed after vaccination with most vaccines, was
bsent in this study. In addition, no other systemic reactions were
bserved and only one transient (5 days), small local reaction (2 cm)
as found after the third vaccination. Necropsy of the vaccine injec-
ion sites, 2 weeks after vaccination, revealed two macroscopically
isible local reactions, characterized by pale tissue discoloration,
hich were composed of limited granulomatous inﬂammatory
issue, which is a normal reaction that can be expected after vac-
ination with a vaccine containing multiple bacterial antigens and
djuvant.
Since Pomona is the most notorious serovar associated with
oetal death [6], the present study focused on efﬁcacy against this
erovar in a controlled laboratory challenge study as well as under
eld conditions. The laboratory challenge study demonstrated that
erovar Pomona was capable of inducing clinical signs (fever and
ethargy), leptospiraemia and foetal death in up to 27% of the con-
rol group. Leptospiruria was not observed in this study; all urine
ultures remained negative. This is in contrast to the results of
odges et al. [4] and Whyte et al. [6] who found urinary shedding
f Pomona after challenge as evidenced by Leptospira positive urine
ultures.
Vaccination resulted in a signiﬁcant reduction in clinical signs,
eptospiraemia and, most importantly, foetal death. The fact that
erovar Pomona was isolated from peritoneal ﬂuid samples of three
ontrol foetuses underlines the relation between this serovar and
eproductive failure. The fact that only three samples were pos-
tive, conﬁrms the difﬁculties associated with the diagnosis ofleptospirosis. Apparently animals can be infected but be culture
negative. Likewise, after laboratory challenge the bacterium can be
isolated from blood for up to 4 days after which the animals become
culture negative, including urine culture, but the Leptospira are still
present in the animal, causing foetal death.
Vaccination induced only low to moderate Pomona speciﬁc
MAT antibody titres and many vaccinates remained seronegative.
Despite this, these vaccinated animals were protected against labo-
ratory challenge. It is possible that very low concentrations (below
the lower limit of quantiﬁcation of the assay) of serum agglutinat-
ing antibodies may  protect against infection. This is in line with
several earlier studies [12–14] which showed that sera from vacci-
nated animals or humans with low or undetectable concentrations
of agglutinating antibodies afforded protection in the passive ham-
ster protection test.
After challenge high antibody titres were induced, especially in
the control animals which had a more marked increase. This is in
line with the results of Whyte et al. [6] and may  be a reﬂection of
vaccine efﬁcacy and rate of antigen exposure in the control animals
compared to the vaccinated animals.
After these promising laboratory results the vaccine was  tested
under ﬁeld conditions on a Portuguese farm with increasing abor-
tion rates associated with Leptospira infection. PCR on aborted
material was  tested Leptospira positive by two  independent labo-
ratories and subsequent serological testing demonstrated Pomona
speciﬁc antibodies whereas other serovars tested virtually nega-
tive.
The study was  designed as an observational-longitudinal ﬁeld
study. After vaccination a rapid, and statistically signiﬁcant, reduc-
tion in abortion rate was manifested, from 12.6% in the winter of
2012 (December 2011 to March 2012) down to 0.5% in the winter
of 2013 (December 2012 to March 2013), a decrease of 96% in the
abortion rate compared to the previous year.
In conclusion, the present studies demonstrate that the octava-
lent vaccine Porcilis® Ery + Parvo + Lepto can be safely used in gilts
and sows and induces statistically signiﬁcant protection that lasts
for at least one year against serovar Pomona induced clinical signs,
leptospiraemia and foetal death. Protection against Pomona asso-
ciated reproductive failure was  conﬁrmed under ﬁeld conditions
where a signiﬁcant reduction in abortion rate was  observed.
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